Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-02-21 @ 4:09 AM
Study NCT ID:
NCT02111850
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2014-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-09
First Submit QC Date:
None
Study First Post Date:
2014-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-12-28
Results First Submit QC Date:
None
Results First Post Date:
2022-03-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-02
Last Update Post Date:
2022-03-29
Last Update Post Date Type:
ACTUAL